Joinn Laboratories(China)Co.,Ltd.

HKSE 6127.HK

Joinn Laboratories(China)Co.,Ltd. Interest Coverage Ratio for the year ending December 31, 2023: 148.25

Joinn Laboratories(China)Co.,Ltd. Interest Coverage Ratio is 148.25 for the year ending December 31, 2023, a -57.19% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Joinn Laboratories(China)Co.,Ltd. Interest Coverage Ratio for the year ending December 31, 2022 was 346.30, a 122.55% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Interest Coverage Ratio for the year ending December 31, 2021 was 155.60, a -63.98% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Interest Coverage Ratio for the year ending December 31, 2020 was 432.05, a -90.46% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Interest Coverage Ratio for the year ending December 31, 2019 was 4,529.57, a 217.66% change year over year.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
Loading...
HKSE: 6127.HK

Joinn Laboratories(China)Co.,Ltd.

CEO Dr. Yuxia Feng M.D.
IPO Date Feb. 26, 2021
Location China
Headquarters A5 Rongjing East Street
Employees 2,510
Sector Health Care
Industries
Description

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

Similar companies

9995.HK

RemeGen Co., Ltd.

USD 1.59

2.46%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 1.70

5.22%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 3.72

2.09%

StockViz Staff

January 15, 2025

Any question? Send us an email